Sensitivity of Pseudomonas aeroginosa Isolated from patients with different clinical state to Antibiotics and determination of some virulance factors in vitro
Article Sidebar
Main Article Content
Abstract
Present study was conducted on 65 isolates belonging to the bacteria P.aeruginosa which included 30 isolates by (46%) of burns, 20 (30%) isolated from urinary tract infections15 (23%) of middle ear infections , tested the sensitivity of the isolates towards (19) antibiotic belonging to (6) groups for different isolates showed a clear divergence in different proportions and in their resistance to antibiotics. It showed antibiotics (Cfepime, Ceftazidim, Imepenime, Amikacin, Tobramicin, Ciprofloxacin, Ofloxacin, Norfloxacin) the most efficient antibiotics used, either antibiotics (Gentamicin ,Streptomycin, Cefixim Augmentin, Cefotaxim, Tobramicin) was medium efficiency either (Cefotetan, Carbencilin, ceftriaxone, Azatrionam, Naldixic acid Piprasilin) was the lowest influential . expressed, 100% of all isolates have ability to produce the enzyme Coagulase and (92.30 %) for each of the enzyme (Licithenase, Haemolycin and Protease), while showed (84.61 %) of the isolates were positive for the examination of enzyme β-lactamase.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1- Typas, A.; Barembruch, A.; Possling, A. and R. Hengge. (2007). Stationary phas reorganisation of the Escherichia coli transcription J. Bacteriol., 178(1): 46-53
2- Mirsalehian, A.; Fezabadi, U.; Akbari, N. and Ameli. (2008). Prevalence of extended spectrum beta lactamases among strains of P. aeruginosa isolates from burn patients. Iranian. Medical. J. ISSN., 11 (3): 244-255.
3- Mittal, R., Aggarwal, S.; Sharma, S.; Chhibber, S.; and Harjai , K . (2009) . Urinary tract infection causing by P. aeruginosa :Aminireview. J.inection and Public Health.,2,101-111.
4- Bradbury, L.; Roddam, A. ;Merritt, D.; Reid, M.; and Sanre, A.(2010) .Champion Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa.J. Medical Microbiology.,84(5-6):499-510.
5- Annette, A.; Angus, G.; David, E.; Jossph, B.; Barbieri, L.; and Fleiszin ,K. (2010). The ADP-Ribosylation Domain of P. aeruginosa exoS is reguired for membrane Bleb nich formation and bacterial survivial within epithilial cells. Infect. Immun., 78(11): 4500-4510.
6- Moradian, F.; Perdosi, E.; and Molana, Z. (2012).Molecular detiction of integron genes and pattern of antibiotic in P. aeruginosa strains isolates from intensive unit.Iran .J. MAM.,1(4):424.
7- Bahmani, N.; Rashid, E.; Ramazanzadeh, Y. (2013).; Detection of SHV type extended-spectrum B-lactamase and risk factors in pseudomonas aeruginosa clinical isolates. Pak. J. Med. Sci.,29(3):788-792 2.
8- Koneman, E.; Winn, W. ; Allen, S.; Janda, W.;Procop, G.;Woods, G.; and Schreckenberger, P. (1997). 'Koneman's Color Atlas and Textbook of Diagnostic Microbiology,' 6thed,. Lippincott Williams & Wilkins, London
9- Collee, J.G.; Fraser, A.G.; Marmion, B.P. and Simmons, A. (1996). "Mackie and McCartney Practical Medical Microbiology". 14th ed., Churchill Livingstone, New York, pp. 413-423.
10- Lennette, E.H.; Ba;ows, A.; Hausler, W.J. and Shadomy, H.J. (1985). "Manual of Clinical Microbiology". 4th ed., American Society for Microbiology, Washington, D.C., pp. 350-372.
11- Cruickshank, R.; Duguid, J.P. and Swain, R.H.A. (1975). Medical Microbiology, a Guide to the Laboratory Diagnosis and Control of Infection. 11th ed., Churchill Livingstone, Edinburgh and London and New York.
12- WHO ,World Health Organization. (1978). Technique for the detection of Lactamas production strain of Enterobacteriaceae. P 52-77.
13- Xiao, H.; Qingzhong, X.; Liui, G.; and Liu, U. (2013). Antibiotic susceptibility and genotype patterns of Pseudomonas aeruginosa from intensive care units mechanical ventilation-associated pneumonia in Biomedical reports 1, 589-593.
14- Mahmoud, A.; Wafaa, A.; Ghada, M.; Rashad, K.; Hindawi, W.; and Amir, R.(2013). Prevalence of Multidrug-Resistant Pseudomonas aeruginosa in Patients with Nosocomial Infections at a University Hospital in Egypt, with Special Reference to Typing Methods .Journal of Virology and Microbiology .,33(4):2344-2357.
15- Kong, K.; Suriya, A.; Ravi, M.; Jayawardena,Y.; Shalaka, K.; Dayaram, F.; Indulkar, K.; and Aimee, d.(2005). Pseudomonas aeruginosa AmpR Is a Global Transcriptional Factor That Re gulates Expression of AmpC and PoxB -Lactamases, Proteases, Quorum Sensing, and Other Virulence Factors. J. Antimicrob. Chemother., 49 (11): 4567–4575.
16- Bjarnsholt, T.; Jensen, P.; Jakobsen, H.; Phipps R.; Nielsen, A.;Rybtke, M.; Nielsen, T.; Givskov, A.; Hoiby, N.; Ciofu, O.(2010). Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLOS.ONE, journal. pone. 5(4): 1371.
17- Jakovljevice, V.; Leonardy, S.; Hoppert, M.; and Anderson ,L. (2008). PilB and Pil Tare ATPase acting antagonistically in type IV pilus function in P. aeruginosa.,. J. Bacteriol., 192(1): 994- 998.
18- Tournier, D.; Richardot,C.;Emeline, E.; Franke, M.; Smith, P.;Asperilla, Q.; and Muller, E. (2013). Co-dexity of resistance mechanisms to Imipenim intensive care unit strains of Pseudomonas aeruginosa. J. Antimicrob. Chemother ., 68(8): 1772-1788.
19- Lim, A.; Pirnay, S.; Vosed, D.; and Vandenelad, C.(2007).Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biobsy specimens and exopectorations by multiple PCR on two outer membrane lipoprotien genes, OprL and OprI. J. Clin. Microbiol., 35(6): 1295-1299.
20- Lamholt, J.; Poulsen, K.; and Killian, J. (2001). Epidemic pobulation structure of P. aeruginosa : Evidence for clone that is pathoginic tothe Eye and that has adistinic combination of virolence factors Infect. Immun., 69(10): 6284- 6295.
21- Adam ,B.; Vasil, A.;A.; and Michael, V. (2004). Anovel extracellular phospholipase C of Pseudomonas aeruginosa requireds of phospholipid monolipid. J. Mol. Mrobiology.,54(4):1089-1098.
23- Mathee, K.; Narasimhan, G.; Valdes, C.; Qiu, X.; Matewish, M.; Koehrsen, M.; Rokas, A.; Yandava, N.; Engels, R.; Zeng, E.; Olavarietta, R.; Doud, M.; Smith, S.; Montgomery, P.; White, J. R.; Godfrey, A.; Kodira, C.; Birren, B.; Galagan, E.; Lory, S. (2008). Dynamics of Pseudomonas aeruginosa genome evolution. Proceedings of the National Academy of Sciences 105 (8): 3100–3105.
24- Trun,I.; Adriana ,V.; Martin, B.; Michael, L.; Vasil, B.; Ehmke, H.; and Pohl, A.(2013). High-level over-expression, purification, and crystallization of a novel phospholipase C/sphingomyelinase from Pseudomonas aeruginosa journal Protein Expression and Purification Mol. Microbiol., 90, 40–46.
26- Martin, J.; Zenilman, J.; Lazarus, G. (2007) Molecular microbiology: new dimensions for cutaneous biology and wound healing. J. Invest Dermatol 130, 38–48.
28- Sumerville, G.; Mikoryak, C.A. and Reitzer, L. (1999). Physiological characterization of Pseudomonas aeruginosa during exotoxin A synthesis: glutamate, iron limitation and aconitase activity. J. Bacteriol., 181(4): 1072-1078.
29- Smith, L.; Barbara, O.; Pholawat, N.; Tingpej, R.; Hua, D.; Tim, F.; Conibear, N.; Jim, H.; and Willcox, M. (2011). Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. Am .J. Respir. Crit. Care Med., 183, 1674–1679
31- Alvarez, C.; Martinez, A.; and P.; Christie, B. (2009). Biological diversity of type IV secretion systems. Microbiol. J. Mol. Biol., 37:775-808